Cargando…
The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
Natural killer (NK) cells can be widely applied for cancer immunotherapy due to their ability to lyse tumor targets without prior sensitization or human leukocyte antigens-matching. Several NK-based therapeutic approaches have been attempted in clinical practice, but their efficacy is not sufficient...
Autores principales: | Kang, Synat, Gao, Xuefeng, Zhang, Li, Yang, Erna, Li, Yonghui, Yu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025748/ https://www.ncbi.nlm.nih.gov/pubmed/33652996 http://dx.doi.org/10.3390/curroncol28020105 |
Ejemplares similares
-
Advances and challenges of immunotherapies in NK/T cell lymphomas
por: He, Ling, et al.
Publicado: (2023) -
Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors
por: Lian, Guangyu, et al.
Publicado: (2021) -
NK cell-based tumor immunotherapy
por: Zhang, Hao, et al.
Publicado: (2023) -
Epigenetic silencing of UBXN8 contributes to leukemogenesis in t(8;21) acute myeloid leukemia
por: Yang, Erna, et al.
Publicado: (2021) -
Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges
por: Kang, Synat, et al.
Publicado: (2022)